We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRY icon
11601
ARS Pharmaceuticals
SPRY
$562M
$70.8K ﹤0.01%
8,297
-89,173
-91% -$579K
OVID icon
11602
Ovid Therapeutics
OVID
$553M
$70.7K ﹤0.01%
+38,028
New +$64.8K
FLL icon
11603
CALL
Full House Resorts
FLL
$81.7M
$70.7K ﹤0.01%
9,400
-5,200
-36% -$36K
PRQR icon
11604
CALL
ProQR Therapeutics
PRQR
$271M
$70.7K ﹤0.01%
19,100
-2,000
-9% -$2.62K
EXFY icon
11605
PUT
Expensify
EXFY
$210M
$70.6K ﹤0.01%
+8,000
New +$89.6K
EQRX
11606
CALL
DELISTED
EQRx, Inc. Common Stock
EQRX
$70.6K ﹤0.01%
28,700
+18,100
+171% +$71.3K
KRMD icon
11607
KORU Medical Systems
KRMD
$157M
$70.6K ﹤0.01%
+19,770
New +$54.5K
CNSL
11608
PUT
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$70.5K ﹤0.01%
19,700
+1,800
+10% +$7.99K
XNCR icon
11609
PUT
Xencor
XNCR
$1.74B
$70.3K ﹤0.01%
+2,700
New +$75.5K
AORT icon
11610
CALL
Artivion
AORT
$1.42B
$70.3K ﹤0.01%
5,800
-11,800
-67% -$142K
SPSM icon
11611
PUT
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.7B
$70.2K ﹤0.01%
+1,900
New +$71.2K
AP icon
11612
Ampco-Pittsburgh
AP
$194M
$70.2K ﹤0.01%
+27,957
New +$86.1K
PLX icon
11613
CALL
Protalix BioTherapeutics
PLX
$179M
$70.1K ﹤0.01%
51,200
+7,300
+17% +$8.01K
ESNT icon
11614
PUT
Essent Group
ESNT
$6.25B
$70K ﹤0.01%
1,800
-7,100
-80% -$270K
LTRX icon
11615
PUT
Lantronix
LTRX
$289M
$70K ﹤0.01%
+16,200
New +$76.2K
OSG
11616
CALL
DELISTED
Overseas Shipholding Group Inc.
OSG
$69.9K ﹤0.01%
24,200
-3,000
-11% -$8.71K
EXPR
11617
PUT
DELISTED
Express, Inc.
EXPR
$69.9K ﹤0.01%
3,425
+1,385
+68% +$33.1K
VIVO
11618
CALL
DELISTED
Meridian Bioscience Inc
VIVO
$69.7K ﹤0.01%
+2,100
New +$67.6K
BSQR
11619
DELISTED
BSQUARE Corporation
BSQR
$69.7K ﹤0.01%
61,686
+47,145
+324% +$52.1K
SYNH
11620
CALL
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$69.7K ﹤0.01%
1,900
-7,100
-79% -$281K
MREO
11621
CALL
Mereo BioPharma
MREO
$50.9M
$69.7K ﹤0.01%
92,900
-6,700
-7% -$5.5K
GILT icon
11622
PUT
Gilat Satellite Networks
GILT
$887M
$69.6K ﹤0.01%
12,000
-576,900
-98% -$3.26M
RING icon
11623
iShares MSCI Global Gold Miners ETF
RING
$2.46B
$69.5K ﹤0.01%
+3,114
New +$64.1K
FCFS icon
11624
PUT
FirstCash
FCFS
$9.31B
$69.5K ﹤0.01%
+800
New +$70.8K
SGC icon
11625
PUT
Superior Group of Companies
SGC
$208M
$69.4K ﹤0.01%
+6,900
New +$66.6K

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.